| T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify… | 46 | 50 | 13,600 | $140 | $11.1M |
| J9271 | Injection, pembrolizumab, 1 mg | 1 | 10 | 810 | $7,760 | $8.7M |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1 | 10 | 4,060 | $1,770 | $7.2M |
| J9299 | Injection, nivolumab, 1 mg | 1 | 10 | 540 | $6,390 | $4M |
| 97535 | A healthcare provider is required to give proper instruction to a person especially in cases of recovery from acute disease. | 90 | 310 | 830 | $120 | $3.7M |
| 77386 | Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex | 1 | 10 | 4,350 | $560 | $3.3M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 4 | 280 | 7,150 | $150 | $3M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 12 | 240 | 4,710 | $150 | $2.6M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1 | 10 | 140 | $3,650 | $2.5M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10 | 70 | 1,650 | $100 | $2M |